FNIP2
Basic information
Region (hg38): 4:158769026-158908050
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FNIP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 51 | 60 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 51 | 10 | 2 |
Variants in FNIP2
This is a list of pathogenic ClinVar variants found in the FNIP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-158769237-C-G | not specified | Uncertain significance (Dec 10, 2024) | ||
4-158769276-G-A | not specified | Uncertain significance (Oct 04, 2024) | ||
4-158769277-C-T | not specified | Uncertain significance (Jun 12, 2023) | ||
4-158825920-T-C | not specified | Uncertain significance (Jul 14, 2021) | ||
4-158825942-A-G | not specified | Uncertain significance (Jul 27, 2024) | ||
4-158825988-A-T | not specified | Uncertain significance (Sep 05, 2024) | ||
4-158829131-G-A | not specified | Uncertain significance (Jun 03, 2024) | ||
4-158831874-C-T | not specified | Uncertain significance (Jan 19, 2024) | ||
4-158833607-T-C | not specified | Uncertain significance (Apr 25, 2022) | ||
4-158851378-C-G | not specified | Uncertain significance (Jun 07, 2023) | ||
4-158859090-A-T | not specified | Uncertain significance (Oct 06, 2021) | ||
4-158859136-A-G | not specified | Uncertain significance (Apr 06, 2024) | ||
4-158859140-G-A | not specified | Uncertain significance (Jun 01, 2023) | ||
4-158859193-T-G | not specified | Uncertain significance (Sep 14, 2022) | ||
4-158859194-T-A | not specified | Uncertain significance (Sep 14, 2022) | ||
4-158859236-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
4-158859585-T-A | not specified | Uncertain significance (Jul 25, 2024) | ||
4-158859639-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
4-158861361-T-C | not specified | Uncertain significance (Jul 20, 2022) | ||
4-158861448-A-G | not specified | Uncertain significance (Oct 03, 2022) | ||
4-158861468-A-G | not specified | Uncertain significance (Feb 14, 2024) | ||
4-158861630-C-T | not specified | Uncertain significance (May 17, 2023) | ||
4-158861662-A-G | not specified | Uncertain significance (Jan 20, 2023) | ||
4-158861711-G-C | not specified | Uncertain significance (Sep 27, 2024) | ||
4-158861713-A-G | not specified | Uncertain significance (Jan 03, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FNIP2 | protein_coding | protein_coding | ENST00000264433 | 17 | 138912 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 6.53e-7 | 124633 | 0 | 7 | 124640 | 0.0000281 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.28 | 517 | 606 | 0.854 | 0.0000325 | 7303 |
Missense in Polyphen | 106 | 180.39 | 0.58761 | 2202 | ||
Synonymous | 0.653 | 213 | 225 | 0.945 | 0.0000128 | 2178 |
Loss of Function | 6.18 | 2 | 48.5 | 0.0413 | 0.00000255 | 581 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000557 | 0.0000556 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000266 | 0.0000265 |
Middle Eastern | 0.0000557 | 0.0000556 |
South Asian | 0.0000654 | 0.0000654 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a co-chaperone of HSP90AA1. Inhibits the ATPase activity of HSP90AA1 leading to reduction in its chaperone activity. Facilitates the binding of client protein FLCN to HSP90AA1 (PubMed:27353360). May play a role in the signal transduction pathway of apoptosis induced by O6-methylguanine- mispaired lesions (By similarity). May be involved in energy and/or nutrient sensing through the AMPK and mTOR signaling pathways (PubMed:18403135). May regulate phosphorylation of RPS6KB1 (PubMed:18663353). {ECO:0000250|UniProtKB:Q80TD3, ECO:0000269|PubMed:18403135, ECO:0000269|PubMed:18663353, ECO:0000269|PubMed:27353360}.;
- Pathway
- mTOR signaling pathway - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.0828
Intolerance Scores
- loftool
- 0.243
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 45.65
Haploinsufficiency Scores
- pHI
- 0.115
- hipred
- Y
- hipred_score
- 0.547
- ghis
- 0.451
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.175
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fnip2
- Phenotype
- neoplasm; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); renal/urinary system phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;regulation of protein phosphorylation;protein phosphorylation;mitochondrion organization;intrinsic apoptotic signaling pathway in response to DNA damage;positive regulation of protein complex assembly;positive regulation of peptidyl-serine phosphorylation;TORC1 signaling;negative regulation of catalytic activity
- Cellular component
- cytoplasm
- Molecular function
- protein binding;ATPase inhibitor activity;chaperone binding